Pharmacodynamics in Iodine Deficiency
When a patient has a baseline deficiency of this trace element, potassium iodide acts as an essential building block. The pharmacological effect in this case is that the drug replenishes the shortage of a specific substrate critically important for normal endocrine function.
This replenishment results in the complete restoration of previously impaired thyroid hormone synthesis. In clinical practice, this mechanism determines the primary indications for use: inorganic non-radioactive iodine preparations are used for the complex treatment of hypothyroidism and reliable prevention of endemic goiter. To achieve a prophylactic effect in endemic goiter, a strictly defined dose of 100 to 200 mcg per day is typically used.
Action Under Normal Iodine Levels
A completely different pharmacological picture is observed when potassium iodide is administered against the background of a normal baseline iodine level. In this situation, the fundamental endocrinological principle of negative feedback is implemented. This phenomenon is known in medical literature as the Wolff–Chaikoff effect (Wolff–Chaikoff effect).
The essence of this effect is that an excessive intake of inorganic iodine causes a paradoxical inhibition of thyroid-stimulating hormone (TSH) secretion. This suppression of TSH secretion occurs at the level of the adenohypophysis (anterior pituitary gland). As a result of this specific inhibition, the drug is also successfully used for goiter prevention, but specifically in patients without baseline iodine deficiency.
Radioprotective Action of Potassium Iodide
The ability of inorganic non-radioactive iodine preparations to act as effective radioprotectors deserves special attention. This property is of critical importance in the event of a threat or actual radiation exposure.
The mechanism of radioprotective action is based on the principle of competitive inhibition. Administration of potassium iodide leads to rapid and massive saturation of thyroid gland tissues with stable (non-radioactive) iodine. Because the glandular pool becomes fully saturated, this physiologically prevents the uptake and subsequent accumulation of dangerous radioactive iodine isotopes that may be released into the environment. Thus, the main indication in this scenario is emergency thyroid protection during radiation exposure.
Adverse Effects
Like any pharmacological agents, iodine preparations can cause a number of adverse reactions that must be kept in mind during therapy. Although potassium iodide is a source of a naturally occurring element, its administration may be accompanied by the following side effects:
- Development of allergic reactions of varying severity.
- Tachycardia (pathological increase in heart rate).
- Insomnia and other sleep disturbances.
Combination Drugs for Hypothyroidism
In modern clinical practice, potassium iodide is frequently prescribed in combination with synthetic hormonal drugs for the treatment of hypothyroidism. Fixed combinations have been developed for patient convenience. The main combination drugs include:
- Iodothyrox: contains a combination of levothyroxine sodium (100 mcg) and potassium iodide (130.8 mcg).
- Thyreocomb: a more complex multi-component drug. It contains levothyroxine sodium (70 mcg), liothyronine (10 mcg), and potassium iodide (150 mcg). Notably, 150 mcg of potassium iodide in this preparation is equivalent to exactly 115 mcg of pure iodine.